Global Anti-nuclear Antibody (ANA) Testing Market Size, Status and Forecast 2020-2026

Global Anti-nuclear Antibody (ANA) Testing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-nuclear Antibody (ANA) Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Indirect Immunofluorescence
1.4.3 Enzyme-linked Immunosorbent Assay (ELISA)
1.4.4 Other
1.5 Market by Application
1.5.1 Global Anti-nuclear Antibody (ANA) Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Anti-nuclear Antibody (ANA) Testing Market Perspective (2015-2026)
2.2 Anti-nuclear Antibody (ANA) Testing Growth Trends by Regions
2.2.1 Anti-nuclear Antibody (ANA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anti-nuclear Antibody (ANA) Testing Historic Market Share by Regions (2015-2020)
2.2.3 Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Anti-nuclear Antibody (ANA) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Anti-nuclear Antibody (ANA) Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Market Size
3.1.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue (2015-2020)
3.1.2 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Anti-nuclear Antibody (ANA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio
3.2.1 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anti-nuclear Antibody (ANA) Testing Revenue in 2019
3.3 Anti-nuclear Antibody (ANA) Testing Key Players Head office and Area Served
3.4 Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service
3.5 Date of Enter into Anti-nuclear Antibody (ANA) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Type (2015-2020)
4.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2021-2026)
5 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Application (2015-2026)
5.1 Global Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020)
5.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Anti-nuclear Antibody (ANA) Testing Market Size (2015-2020)
6.2 Anti-nuclear Antibody (ANA) Testing Key Players in North America (2019-2020)
6.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020)
6.4 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size (2015-2020)
7.2 Anti-nuclear Antibody (ANA) Testing Key Players in Europe (2019-2020)
7.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020)
7.4 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020)
8 China
8.1 China Anti-nuclear Antibody (ANA) Testing Market Size (2015-2020)
8.2 Anti-nuclear Antibody (ANA) Testing Key Players in China (2019-2020)
8.3 China Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020)
8.4 China Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Anti-nuclear Antibody (ANA) Testing Market Size (2015-2020)
9.2 Anti-nuclear Antibody (ANA) Testing Key Players in Japan (2019-2020)
9.3 Japan Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020)
9.4 Japan Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size (2015-2020)
10.2 Anti-nuclear Antibody (ANA) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020)
11 India
11.1 India Anti-nuclear Antibody (ANA) Testing Market Size (2015-2020)
11.2 Anti-nuclear Antibody (ANA) Testing Key Players in India (2019-2020)
11.3 India Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020)
11.4 India Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Anti-nuclear Antibody (ANA) Testing Market Size (2015-2020)
12.2 Anti-nuclear Antibody (ANA) Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020)
12.4 Central & South America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Abcam
13.1.1 Abcam Company Details
13.1.2 Abcam Business Overview and Its Total Revenue
13.1.3 Abcam Anti-nuclear Antibody (ANA) Testing Introduction
13.1.4 Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020))
13.1.5 Abcam Recent Development
13.2 Antibodies
13.2.1 Antibodies Company Details
13.2.2 Antibodies Business Overview and Its Total Revenue
13.2.3 Antibodies Anti-nuclear Antibody (ANA) Testing Introduction
13.2.4 Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.2.5 Antibodies Recent Development
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Details
13.3.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.3.3 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Introduction
13.3.4 Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.3.5 Bio-Rad Laboratories Recent Development
13.4 Alere
13.4.1 Alere Company Details
13.4.2 Alere Business Overview and Its Total Revenue
13.4.3 Alere Anti-nuclear Antibody (ANA) Testing Introduction
13.4.4 Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.4.5 Alere Recent Development
13.5 Erba Diagnostics
13.5.1 Erba Diagnostics Company Details
13.5.2 Erba Diagnostics Business Overview and Its Total Revenue
13.5.3 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Introduction
13.5.4 Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.5.5 Erba Diagnostics Recent Development
13.6 MBL International
13.6.1 MBL International Company Details
13.6.2 MBL International Business Overview and Its Total Revenue
13.6.3 MBL International Anti-nuclear Antibody (ANA) Testing Introduction
13.6.4 MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.6.5 MBL International Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview and Its Total Revenue
13.7.3 Merck Anti-nuclear Antibody (ANA) Testing Introduction
13.7.4 Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Indur Services
13.8.1 Indur Services Company Details
13.8.2 Indur Services Business Overview and Its Total Revenue
13.8.3 Indur Services Anti-nuclear Antibody (ANA) Testing Introduction
13.8.4 Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.8.5 Indur Services Recent Development
13.9 Trinity Biotech
13.9.1 Trinity Biotech Company Details
13.9.2 Trinity Biotech Business Overview and Its Total Revenue
13.9.3 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Introduction
13.9.4 Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.9.5 Trinity Biotech Recent Development
13.10 Thermo Fisher Scientific
13.10.1 Thermo Fisher Scientific Company Details
13.10.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.10.3 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Introduction
13.10.4 Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
13.10.5 Thermo Fisher Scientific Recent Development
13.11 Zeus Scientific
10.11.1 Zeus Scientific Company Details
10.11.2 Zeus Scientific Business Overview and Its Total Revenue
10.11.3 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Introduction
10.11.4 Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
10.11.5 Zeus Scientific Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Anti-nuclear Antibody (ANA) Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-nuclear Antibody (ANA) Testing Revenue
Table 3. Ranking of Global Top Anti-nuclear Antibody (ANA) Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Indirect Immunofluorescence
Table 6. Key Players of Enzyme-linked Immunosorbent Assay (ELISA)
Table 7. Key Players of Other
Table 8. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Anti-nuclear Antibody (ANA) Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Anti-nuclear Antibody (ANA) Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2015-2020)
Table 12. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Anti-nuclear Antibody (ANA) Testing Market Growth Strategy
Table 18. Main Points Interviewed from Key Anti-nuclear Antibody (ANA) Testing Players
Table 19. Global Anti-nuclear Antibody (ANA) Testing Revenue by Players (2015-2020) (Million US$)
Table 20. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players (2015-2020)
Table 21. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2019)
Table 22. Global Anti-nuclear Antibody (ANA) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service
Table 25. Date of Enter into Anti-nuclear Antibody (ANA) Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020) (Million US$)
Table 28. Global Anti-nuclear Antibody (ANA) Testing Market Size Share by Type (2015-2020)
Table 29. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2021-2026)
Table 30. Global Anti-nuclear Antibody (ANA) Testing Market Size Share by Application (2015-2020)
Table 31. Global Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020) (Million US$)
Table 32. Global Anti-nuclear Antibody (ANA) Testing Market Size Share by Application (2021-2026)
Table 33. North America Key Players Anti-nuclear Antibody (ANA) Testing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Anti-nuclear Antibody (ANA) Testing Market Share (2019-2020)
Table 35. North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020) (Million US$)
Table 36. North America Anti-nuclear Antibody (ANA) Testing Market Share by Type (2015-2020)
Table 37. North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020) (Million US$)
Table 38. North America Anti-nuclear Antibody (ANA) Testing Market Share by Application (2015-2020)
Table 39. Europe Key Players Anti-nuclear Antibody (ANA) Testing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Anti-nuclear Antibody (ANA) Testing Market Share (2019-2020)
Table 41. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Type (2015-2020)
Table 43. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Application (2015-2020)
Table 45. China Key Players Anti-nuclear Antibody (ANA) Testing Revenue (2019-2020) (Million US$)
Table 46. China Key Players Anti-nuclear Antibody (ANA) Testing Market Share (2019-2020)
Table 47. China Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020) (Million US$)
Table 48. China Anti-nuclear Antibody (ANA) Testing Market Share by Type (2015-2020)
Table 49. China Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020) (Million US$)
Table 50. China Anti-nuclear Antibody (ANA) Testing Market Share by Application (2015-2020)
Table 51. Japan Key Players Anti-nuclear Antibody (ANA) Testing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Anti-nuclear Antibody (ANA) Testing Market Share (2019-2020)
Table 53. Japan Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Anti-nuclear Antibody (ANA) Testing Market Share by Type (2015-2020)
Table 55. Japan Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Anti-nuclear Antibody (ANA) Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Anti-nuclear Antibody (ANA) Testing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Anti-nuclear Antibody (ANA) Testing Market Share (2019-2020)
Table 59. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Share by Type (2015-2020)
Table 61. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Share by Application (2015-2020)
Table 63. India Key Players Anti-nuclear Antibody (ANA) Testing Revenue (2019-2020) (Million US$)
Table 64. India Key Players Anti-nuclear Antibody (ANA) Testing Market Share (2019-2020)
Table 65. India Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020) (Million US$)
Table 66. India Anti-nuclear Antibody (ANA) Testing Market Share by Type (2015-2020)
Table 67. India Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020) (Million US$)
Table 68. India Anti-nuclear Antibody (ANA) Testing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Anti-nuclear Antibody (ANA) Testing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Anti-nuclear Antibody (ANA) Testing Market Share (2019-2020)
Table 71. Central & South America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Anti-nuclear Antibody (ANA) Testing Market Share by Type (2015-2020)
Table 73. Central & South America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Anti-nuclear Antibody (ANA) Testing Market Share by Application (2015-2020)
Table 75. Abcam Company Details
Table 76. Abcam Business Overview
Table 77. Abcam Product
Table 78. Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 79. Abcam Recent Development
Table 80. Antibodies Company Details
Table 81. Antibodies Business Overview
Table 82. Antibodies Product
Table 83. Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 84. Antibodies Recent Development
Table 85. Bio-Rad Laboratories Company Details
Table 86. Bio-Rad Laboratories Business Overview
Table 87. Bio-Rad Laboratories Product
Table 88. Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 89. Bio-Rad Laboratories Recent Development
Table 90. Alere Company Details
Table 91. Alere Business Overview
Table 92. Alere Product
Table 93. Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 94. Alere Recent Development
Table 95. Erba Diagnostics Company Details
Table 96. Erba Diagnostics Business Overview
Table 97. Erba Diagnostics Product
Table 98. Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 99. Erba Diagnostics Recent Development
Table 100. MBL International Company Details
Table 101. MBL International Business Overview
Table 102. MBL International Product
Table 103. MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 104. MBL International Recent Development
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Product
Table 108. Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 109. Merck Recent Development
Table 110. Indur Services Business Overview
Table 111. Indur Services Product
Table 112. Indur Services Company Details
Table 113. Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 114. Indur Services Recent Development
Table 115. Trinity Biotech Company Details
Table 116. Trinity Biotech Business Overview
Table 117. Trinity Biotech Product
Table 118. Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 119. Trinity Biotech Recent Development
Table 120. Thermo Fisher Scientific Company Details
Table 121. Thermo Fisher Scientific Business Overview
Table 122. Thermo Fisher Scientific Product
Table 123. Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 124. Thermo Fisher Scientific Recent Development
Table 125. Zeus Scientific Company Details
Table 126. Zeus Scientific Business Overview
Table 127. Zeus Scientific Product
Table 128. Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2015-2020) (Million US$)
Table 129. Zeus Scientific Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-nuclear Antibody (ANA) Testing Market Share by Type: 2020 VS 2026
Figure 2. Indirect Immunofluorescence Features
Figure 3. Enzyme-linked Immunosorbent Assay (ELISA) Features
Figure 4. Other Features
Figure 5. Global Anti-nuclear Antibody (ANA) Testing Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Anti-nuclear Antibody (ANA) Testing Report Years Considered
Figure 10. Global Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players in 2019
Figure 15. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue in 2019
Figure 17. North America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Abcam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Abcam Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 26. Antibodies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Antibodies Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 28. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bio-Rad Laboratories Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 30. Alere Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Alere Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 32. Erba Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Erba Diagnostics Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 34. MBL International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. MBL International Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 36. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Merck Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 38. Indur Services Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Indur Services Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 40. Trinity Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Trinity Biotech Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 42. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Thermo Fisher Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 44. Zeus Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Zeus Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028

Published: 10-Jan-2024        Price: US 4950 Onwards        Pages: 309

“Rising focus on decentralized diagnostics is driving the overall growth of the infectious disease diagnostics market.” The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. The rising focus on decentralized diagnostics and the growing demand for CLIA-waived PoC tests have driven the use of PoC technologies. The trend towa......

Global Pharmaceutical Testing Services Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 102

Pharmaceutical Testing Service is often used to identify The chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict The medication's ability to reach a specific target within The body. Testing may even reveal contamination in The manufacturing production process or highlight other,......

Global Pharmaceutical Testing Services Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156

According to our LPI (LP Information) latest study, the global Pharmaceutical Testing Services market size was valued at US$ 3398.6 million in 2023. With growing demand in downstream market, the Pharmaceutical Testing Services is forecast to a readjusted size of US$ 7008.4 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Pharmaceutical Testing Services market. Pharmaceutical Testing Services are expected to show ......

Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 624.1 million in 2023. With growing demand in downstream market, the Helicobacter Pylori Diagnostics is forecast to a readjusted size of US$ 1040.4 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Helicobacter Pylori Diagnostics market. Helicobacter Pylori Diagnostics are expected to show st......

Global Laboratory-developed Testing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Laboratory-developed Testing market size was valued at US$ 3442.2 million in 2023. With growing demand in downstream market, the Laboratory-developed Testing is forecast to a readjusted size of US$ 4512 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Laboratory-developed Testing market. Laboratory-developed Testing are expected to show stable growth i......

Global Laboratory-developed Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109

According to our (Global Info Research) latest study, the global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2023 and is forecast to a readjusted size of USD 4649.1 million by 2030 with a CAGR of 3.6% during review period. Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vit......

Global Pharmaceutical Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 151

According to our (Global Info Research) latest study, the global Pharmaceutical Testing Services market size was valued at USD 3574.8 million in 2023 and is forecast to a readjusted size of USD 6987.8 million by 2030 with a CAGR of 10.0% during review period. Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and s......

Global TB Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global TB Diagnostic market: According to our latest research, the global TB Diagnostic market looks promising in the next 5 years. As of 2022, the global TB Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global TB Diagnostic market, with a sys......

IVD Products - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for IVD Products, with both quantitative a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs